Tag: pharmaceutical tariffs

  • Pharma 100%

    The second tranche of Section 232 pharmaceutical duties reaches every remaining drugmaker this week, and the companies most exposed are the ones least able to build a factory WASHINGTON, September 30, 2026. The broadest tariff ever applied to medicines entering the United States took effect this week, extending duties of up to 100 percent on…

  • From Loading Dock to Trade Strategy: What DSV’s Luxembourg-Indianapolis Pharma Air Route Reveals About the New Tariff Era

    Peacock Tariff Consulting · June 2026 On 9 June 2026, DSV did something that, on its face, looks like a routine logistics announcement: the world’s largest freight forwarder opened a dedicated pharmaceutical air corridor between Luxembourg and Indianapolis. A new lane, a new hub, a press release full of the usual language about visibility, reliability…

  • Lilly Doubles Down on Lebanon: $4.5 Billion More for Indiana

    Lilly Doubles Down on Lebanon: $4.5 Billion More for Indiana

    A window into how Washington is now buying American pharmaceutical capacity and what the Lebanon expansion tells us about the new U.S. industrial-policy architecture for pharma Eli Lilly is making another major investment in U.S. manufacturing, announcing plans to spend an additional $4.5 billion at two of its sites in Lebanon, Indiana. The headline figure…